1887

Abstract

Bovine respiratory syncytial virus (BRSV) causes inflammation and obstruction of the small airways, leading to severe respiratory disease in young calves. The virus is closely related to human (H)RSV, a major cause of bronchiolitis and pneumonia in young children. The ability to manipulate the genome of RSV has provided opportunities for the development of stable, live attenuated RSV vaccines. The role of the SH protein in the pathogenesis of BRSV was evaluated and using a recombinant (r)BRSV in which the SH gene had been deleted. Infection of bovine epithelial cells and monocytes with rBRSVΔSH, , resulted in an increase in apoptosis, and higher levels of TNF-α and IL-1β compared with cells infected with parental, wild-type (WT) rBRSV. Although replication of rBRSVΔSH and WT rBRSV, , were similar, the replication of rBRSVΔSH was moderately reduced in the lower, but not the upper, respiratory tract of experimentally infected calves. Despite the greater ability of rBRSVΔSH to induce pro-inflammatory cytokines, , the pulmonary inflammatory response in rBRSVΔSH-infected calves was significantly reduced compared with that in calves inoculated with WT rBRSV, 6 days previously. Virus lacking SH appeared to be as immunogenic and effective in inducing resistance to virulent virus challenge, 6 months later, as the parental rBRSV. These findings suggest that rBRSVΔSH may be an ideal live attenuated virus vaccine candidate, combining safety with a high level of immunogenicity.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.064931-0
2014-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/6/1244.html?itemId=/content/journal/jgv/10.1099/vir.0.064931-0&mimeType=html&fmt=ahah

References

  1. Bermejo-Martin J. F., Garcia-Arevalo M. C., Alonso A., De Lejarazu R. O., Pino M., Resino S., Tenorio A., Bernardo D., Leon A. J. other authors 2007; Persistence of proinflammatory response after severe respiratory syncytial virus disease in children. J Allergy Clin Immunol 119:1547–1550 [View Article][PubMed]
    [Google Scholar]
  2. Bukreyev A., Whitehead S. S., Murphy B. R., Collins P. L. 1997; Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J Virol 71:8973–8982[PubMed]
    [Google Scholar]
  3. Carter S. D., Dent K. C., Atkins E., Foster T. L., Verow M., Gorny P., Harris M., Hiscox J. A., Ranson N. A. other authors 2010; Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability. FEBS Lett 584:2786–2790 [View Article][PubMed]
    [Google Scholar]
  4. Cristina J., Yunus A. S., Rockemann D. D., Samal S. K. 2001; Bovine respiratory syncytial virus can induce apoptosis in MDBK cultured cells. Vet Microbiol 83:317–320 [View Article][PubMed]
    [Google Scholar]
  5. Dennis M. J., Davies D. C., Hoare M. N. 1976; A simplified apparatus for the microbiological isolation of calves. Br Vet J 132:642–646[PubMed]
    [Google Scholar]
  6. Dinarello C. A., Cannon J. G., Wolff S. M., Bernheim H. A., Beutler B., Cerami A., Figari I. S., Palladino M. A. Jr, O’Connor J. V. 1986; Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163:1433–1450 [View Article][PubMed]
    [Google Scholar]
  7. Fach S. J., Olivier A., Gallup J. M., Waters T. E., Ackermann M. R., Lehmkuhl H. D., Sacco R. E. 2010; Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or Toll-like receptor ligation. Vet Immunol Immunopathol 136:55–64 [View Article][PubMed]
    [Google Scholar]
  8. Franchi L., Eigenbrod T., Núñez G. 2009; Cutting edge: TNF-α mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183:792–796 [View Article][PubMed]
    [Google Scholar]
  9. Fuentes S., Tran K. C., Luthra P., Teng M. N., He B. 2007; Function of the respiratory syncytial virus small hydrophobic protein. J Virol 81:8361–8366 [View Article][PubMed]
    [Google Scholar]
  10. Gan S. W., Tan E., Lin X., Yu D., Wang J., Tan G. M., Vararattanavech A., Yeo C. Y., Soon C. H. other authors 2012; The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels. J Biol Chem 287:24671–24689 [View Article][PubMed]
    [Google Scholar]
  11. He B., Lin G. Y., Durbin J. E., Durbin R. K., Lamb R. A. 2001; The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol 75:4068–4079 [View Article][PubMed]
    [Google Scholar]
  12. Ichinohe T., Lee H. K., Ogura Y., Flavell R., Iwasaki A. 2009; Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206:79–87 [View Article][PubMed]
    [Google Scholar]
  13. Ichinohe T., Pang I. K., Iwasaki A. 2010; Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol 11:404–410 [View Article][PubMed]
    [Google Scholar]
  14. Ito M., Yanagi Y., Ichinohe T. 2012; Encephalomyocarditis virus viroporin 2B activates NLRP3 inflammasome. PLoS Pathog 8:e1002857 [View Article][PubMed]
    [Google Scholar]
  15. Johnson J. E., Gonzales R. A., Olson S. J., Wright P. F., Graham B. S. 2007; The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20:108–119 [View Article][PubMed]
    [Google Scholar]
  16. Karger A., Schmidt U., Buchholz U. J. 2001; Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin. J Gen Virol 82:631–640[PubMed]
    [Google Scholar]
  17. Karron R. A., Wright P. F., Belshe R. B., Thumar B., Casey R., Newman F., Polack F. P., Randolph V. B., Deatly A. other authors 2005; Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis 191:1093–1104 [View Article][PubMed]
    [Google Scholar]
  18. Kennedy H. E., Jones B. V., Tucker E. M., Ford N. J., Clarke S. W., Furze J., Thomas L. H., Stott E. J. 1988; Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus. J Gen Virol 69:3023–3032 [View Article][PubMed]
    [Google Scholar]
  19. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. 1969; Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89:422–434[PubMed]
    [Google Scholar]
  20. Kotelkin A., Prikhod’ko E. A., Cohen J. I., Collins P. L., Bukreyev A. 2003; Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 77:9156–9172 [View Article][PubMed]
    [Google Scholar]
  21. Kwong L. S., Thom M., Sopp P., Rocchi M., Wattegedera S., Entrican G., Hope J. C. 2010; Production and characterization of two monoclonal antibodies to bovine tumour necrosis factor alpha (TNF-α) and their cross-reactivity with ovine TNF-α. Vet Immunol Immunopathol 135:320–324 [View Article][PubMed]
    [Google Scholar]
  22. Li Z., Gabbard J. D., Mooney A., Chen Z., Tompkins S. M., He B. 2013; Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza A virus in mice. J Virol 87:9604–9609 [View Article][PubMed]
    [Google Scholar]
  23. Lin Y., Bright A. C., Rothermel T. A., He B. 2003; Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J Virol 77:3371–3383 [View Article][PubMed]
    [Google Scholar]
  24. Meyer G., Deplanche M., Schelcher F. 2008; Human and bovine respiratory syncytial virus vaccine research and development. Comp Immunol Microbiol Infect Dis 31:191–225 [View Article][PubMed]
    [Google Scholar]
  25. Nair H., Nokes D. J., Gessner B. D., Dherani M., Madhi S. A., Singleton R. J., O’Brien K. L., Roca A., Wright P. F. other authors 2010; Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545–1555 [View Article][PubMed]
    [Google Scholar]
  26. Perez M., García-Barreno B., Melero J. A., Carrasco L., Guinea R. 1997; Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology 235:342–351 [View Article][PubMed]
    [Google Scholar]
  27. Polack F. P., Irusta P. M., Hoffman S. J., Schiatti M. P., Melendi G. A., Delgado M. F., Laham F. R., Thumar B., Hendry R. M. other authors 2005; The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc Natl Acad Sci U S A 102:8996–9001 [View Article][PubMed]
    [Google Scholar]
  28. Pulmanausahakul R., Faber M., Morimoto K., Spitsin S., Weihe E., Hooper D. C., Schnell M. J., Dietzschold B. 2001; Overexpression of cytochrome c by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. J Virol 75:10800–10807 [View Article][PubMed]
    [Google Scholar]
  29. Rutigliano J. A., Graham B. S. 2004; Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol 173:3408–3417[PubMed] [CrossRef]
    [Google Scholar]
  30. Samal S. K., Zamora M. 1991; Nucleotide sequence analysis of a matrix and small hydrophobic protein dicistronic mRNA of bovine respiratory syncytial virus demonstrates extensive sequence divergence of the small hydrophobic protein from that of human respiratory syncytial virus. J Gen Virol 72:1715–1720 [View Article][PubMed]
    [Google Scholar]
  31. Schmitz N., Kurrer M., Bachmann M. F., Kopf M. 2005; Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 79:6441–6448 [View Article][PubMed]
    [Google Scholar]
  32. Schreiber P., Matheise J. P., Dessy F., Heimann M., Letesson J. J., Coppe P., Collard A. 2000; High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine. J Vet Med B Infect Dis Vet Public Health 47:535–550 [View Article][PubMed]
    [Google Scholar]
  33. Segovia J., Sabbah A., Mgbemena V., Tsai S. Y., Chang T. H., Berton M. T., Morris I. R., Allen I. C., Ting J. P., Bose S. 2012; TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS ONE 7:e29695 [View Article][PubMed]
    [Google Scholar]
  34. Sopp P., Howard C. J. 1997; Cross-reactivity of monoclonal antibodies to defined human leucocyte differentiation antigens with bovine cells. Vet Immunol Immunopathol 56:11–25 [View Article][PubMed]
    [Google Scholar]
  35. Spann K. M., Collinds P. L., Teng M. N. 2003; Genetic recombination during coinfection of two mutants of human respiratory syncytial virus. J Virol 77:11201–11211 [View Article][PubMed]
    [Google Scholar]
  36. Staib C., Kisling S., Erfle V., Sutter G. 2005; Inactivation of the viral interleukin 1β receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J Gen Virol 86:1997–2006 [View Article][PubMed]
    [Google Scholar]
  37. Stott E. J., Taylor G. 1985; Respiratory syncytial virus. Arch Virol 84:1–52 [View Article][PubMed]
    [Google Scholar]
  38. Taylor G., Thomas L. H., Wyld S. G., Furze J., Sopp P., Howard C. J. 1995; Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J Virol 69:6658–6664[PubMed]
    [Google Scholar]
  39. Thomas L. H., Gourlay R. N., Stott E. J., Howard C. J., Bridger J. C. 1982; A search for new microorganisms in calf pneumonia by the inoculation of gnotobiotic calves. Res Vet Sci 33:170–182[PubMed]
    [Google Scholar]
  40. Thomas L. H., Slott E. J., Collins A. P., Jebbett J. 1984; Experimental pneumonia in gnotobiotic calves produced by respiratory syncytial virus. Br J Exp Pathol 65:19–28[PubMed]
    [Google Scholar]
  41. Thomas P. G., Dash P., Aldridge J. R. Jr, Ellebedy A. H., Reynolds C., Funk A. J., Martin W. J., Lamkanfi M., Webby R. J. other authors 2009; The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30:566–575 [View Article][PubMed]
    [Google Scholar]
  42. Triantafilou K., Kar S., Vakakis E., Kotecha S., Triantafilou M. 2013; Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax 68:66–75 [View Article][PubMed]
    [Google Scholar]
  43. Valarcher J.-F., Schelcher F., Bourhy H. 2000; Evolution of bovine respiratory syncytial virus. J Virol 74:10714–10728 [View Article][PubMed]
    [Google Scholar]
  44. Valarcher J.-F., Furze J., Wyld S., Cook R., Conzelmann K.-K., Taylor G. 2003; Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 77:8426–8439 [View Article][PubMed]
    [Google Scholar]
  45. van der Poel W. H., Schrijver R. S., Middel W. G., Kramps J. A., Brand A., Van Oirschot J. T. 1996; Experimental reproduction of respiratory disease in calves with non-cell-culture-passaged bovine respiratory syncytial virus. Vet Q 18:81–86 [View Article][PubMed]
    [Google Scholar]
  46. Viuff B., Tjørnehøj K., Larsen L. E., Røntved C. M., Uttenthal A., Rønsholt L., Alexandersen S. 2002; Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus. Am J Pathol 161:2195–2207 [View Article][PubMed]
    [Google Scholar]
  47. Welliver T. P., Garofalo R. P., Hosakote Y., Hintz K. H., Avendano L., Sanchez K., Velozo L., Jafri H., Chavez-Bueno S. other authors 2007; Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195:1126–1136 [View Article][PubMed]
    [Google Scholar]
  48. Werling D., Collins R. A., Taylor G., Howard C. J. 2002; Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus. J Leukoc Biol 72:297–304[PubMed]
    [Google Scholar]
  49. Whitehead S. S., Bukreyev A., Teng M. N., Firestone C.-Y., St Claire M., Elkins W. R., Collins P. L., Murphy B. R. 1999; Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J Virol 73:3438–3442[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.064931-0
Loading
/content/journal/jgv/10.1099/vir.0.064931-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error